DAFTAR PUSTAKA

1. Hartl R, Geber LM, Ni Q, Ghajar J. Effect of Early Nutrition on Deaths due to Severe
Traumatic Brain injury. Journal of Neurosurgery.2008; 109: 50-56.
2. Beaumont A, Marmau A. Response of The Brain to Phsysical Injury: Neurosurgery of
The Scientific Basis of Clinical Practice. London: Blackwell science Ltd 2003;3 (1).
3. Iskandar J. Cedera Kepala. Jakarta: PT Bhuana Ilmu populer; 2004.
4. Narayan RK, Wilberger JE, Povlishock JT. Neurotrauma; Neuropathology of Head
Injury, Emergency Room Management of The Head injured Patient. USA: Mc Graw
Hill; 1996.
5. Setti RS, Richard EG. Principles of Neurosurgery: increase intracranial pressure,
cerebral edema, and brain herniation. Edisi ke-2. Philladelphia USA: Elseveier
Mosby;2005.
6. Julian YR. Neurological surgery: Intracranial Pressure. Edisi ke-4. Volume 1.
California USA: W.B Sounders Company; 1996.
7. Shohami E, Ginis I, Hallenbac, JM. Dual Role Of Tumour Necrosis Factor alpha in
Brain Injury. Cytokines Growth factor Rev 1999; 10 (2):119-30.
8. Knoblach SM, Faden Al. Interleukin-10 Improves Outcome and Alter Proinflamatory
Cytokines Expression after Experimental Traumatic Brain Injury. Exp Neurol 1998;
153 (1);143-51
9. DSTC, 2008. Patofisiologi trauma. 2-18
10. Kewal, K Jain, MD,FRACS.FFPM. The Handbook Of Neuroprotection. Jain Pharma
Biotech,Bagel, Switzerland. 2011;1-2.
11. Sumber: http://www.tbiomed.com
12. Zollman FS. Manual Of Traumatic Brain Injury Management.Edisi. Crandall M,
penyunting. New York: Demos Medical Publishing; 2011.
13. Narayan RK SK. Closed head injury. Dalam: Rengachary S ER, penyunting.
Principles of neurosurgery.Edisi ke- 2. Philadelphia: Elsevier Mosby Limited; 2006.
h. 301-17.
14. Jain KK. The Handbook of Neuroprotection. 2011.
15. Arifin M. Pengaruh pemberian glutation terhadap ekspresi gen NR2B dan kaspase-3
jaringan otak tikus pascacedera otak traumatika. . journal Article. 2010.
16. Schmit IM, Heyde. . The role of neuroinflammation in traumatic brain injury.
european journal of trauma. 2004;30.
17. Veenith T, Goon SS, Burnstein RM. Molecular mechanisms of traumatic brain injury:
the missing link om management. World Journal of Emergency Surgery.
2009;4(17):1-6.

18. Mechoulam R, Panikashvili D, Shohami E. Cabbabinoids and brain injury:

therapeutic implication. Trends in Molecular Medicine. 2002;8(2):58-61.
19. Coronado V, Xu L, Basavaraju S, McGuire L, Wald M, Faul M, et al. Surveillance for
traimatic brain injury-related death-United States, 1997-2007. Morbidity and
Mortality Weekly Report. 2011;60(5):1-32.
20. Murthy TVSP BP, Sandhu K, Prabhakar T, Gogna RL. Secondary brain injury:
prevention and intensive care management. IJNT. 2005;2(1).
21. Warner, Engelhard. Pathophysiology of traumatic brain injury2112.
22. Kasan U. Cidera Kepala: patofisiologi,penanganan dan biomolekuler. Surabaya:
Bag/SMF Ilmu Bedah Saraf FK Unair/RSU Dr Soetomo 2006.
23. Bisri T. Patofisiologi cedera kepala akut.Edisi. Bandung: Fakul. Kedok.Unpad; 2012.
24. Israelsson C. Molecular characterization of experimental traumatic brain injury.
Uppsala Dissertation. 2006(Faculty of Medicine Uppsala Universiteit.).
25. Schulz JB LJ, Seyfried J, Dichgans J. . Glutathione, oxidative stress and
neurodegeneration. Eur J Biochem. 2000;267.
26. Schmidley J. Current concepts of cerebrovascular disease and stroke, edisi 1990.
27. Jain KK. The Handbook of Neuroprotection. 2011.
28. Mechoulam S. Endocannabinoid and traumatic brain injury. JCerebral blood flow and
methabolism. 2007;36(Mol.Neurobiol.).
29. McAllister TW. Neurobiological consequences of traumatic brain injury. Dialogues in
Clinical Neuroscience. 2011;13(3):287-300.
30. Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, Gruen RL.
Early management of severe traumatic brain injury. The Lancet.
2012;380(9847):1088-98.
31. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of
The Cell 4ed Edisi. New York: Garland Science Taylor & Francis Group; 2002.
32. Wijanarka A D. Implementasi clinical governance: pengembangan indikator klinik
cedera kepala di Instalasi Gawat Darurat. JMPK. 2005;8(4).
33. Turschan a. Cedera otak dan penatalaksanaannya 2009.
34. Stuart A, Rothwel. Inflammation in central nervous system injury. Cytokine and
acute neuroregenerations.Edisi. Manchester, UK: Royal siciety; 2003.
35. Sugawara T. Neuronal death/survival signaling pathways in cerebral ischemia. Am J
Soc for Exper Neuro Therap. 2004;1.
36. R S. Buku Ajar Ilmu Bedah. Jakarta: EGC Penerbit Buku Kedokteran; 2004.
37. Shawn Marshall MB, Scott McCullagh, Diana Velikonja, Lindsay Berrigan. Clinical
Practice Guidelines for Mild Traumatic Brain Injury and Persistent Symptoms.
38. Salgado SV. Apoptotic and Antiapoptotic Mechanisms in Neurons and Glial Cells
after Damage to the Immature Brain. Barcelona: Autonoma de Barcelona; 2007.
39. Kumar A, Fausto, Mitchel. Robin Basic Pathology. 8th ed. USA: Saunders Elsevier;
2007.
40. Karnen G B,Rengganis I, Imunologi Dasar,edisi IX, 2010, Balai penerbit FKUI;222227

41. Boato Francesco,Boato et al, journal of neuroinflamation,2011;8;183

42. TVSP Murthy MD,Indian Journal of Neurotrauma (IJNT) 2008,vol 5, No1; p41-44
43. Rossant jain et all,Propofol: neuroprotection in an in vitro model of traumatic brain
injury,departement of Anesthesiology,RWTH Aachen University Hospital,
Aachen,Germany;27 April 2009.
44. Mc Keage Katty and caroline M perry;propofol: A review is use in intensive care
sedation of adults,New Zealand; A dis International Limited;2003;17(4):235-272.
45. Soenarjo dkk,Anestesiology. Semarang; bagian anestesiologi dan terapi intensif
Fakultas Kedokteran UNDIP/RSUP Kariadi;2010.